ImmunoMind

Operator of a biomarker discovery platform dedicated to providing immune-based diagnostics and treatment solutions for viral infections. The company’s platform accelerates vaccine development and discovery of broadly neutralizing antibodies from single-cell, thereby enabling biopharma and research organizations to gain clinical insights from immune cell data.